A Program for Relapse Prevention in Schizophrenia
نویسندگان
چکیده
منابع مشابه
Antipsychotic drugs for relapse prevention in schizophrenia.
www.thelancet.com Vol 380 September 22, 2012 1055 trial requires it to be viewed in the context of the totality of evidence; the estimates of eff ect seen in IST-3 were comparable with, and reinforced the results of, previous trials. Fatovich and colleagues state that we had decided “ordinal analysis was not appropriate”; this was the view of the steering committee in 2009. However, as stated i...
متن کاملProdromal symptoms and relapse prevention in schizophrenia.
The value of monitoring for prodromal symptoms in patients with schizophrenia has been questioned by some investigators who point out that their positive predictive value, sensitivity, and specificity can be low in relation to relapse. This article focuses on methodological and conceptual issues which should be considered in evaluating the usefulness of prodromal symptoms and behaviors as part ...
متن کاملO8: A Prevention Program for Postpartum OCD
There has been a recent rise in research focused on maternal psychological conditions during the perinatal period. Although the majority of investigations have examined postpartum depression, there is a growing appreciation for the deleterious consequences of maternal anxiety in the perinatal period for both the mother and child. Obsessive compulsive disorder (OCD), in particular, has emerged a...
متن کاملITAREPS: information technology aided relapse prevention programme in schizophrenia.
ITAREPS presents a mobile phone-based telemedicine solution for weekly remote patient monitoring and disease management in schizophrenia and psychotic disorders in general. The programme provides health professionals with home telemonitoring via a PC-to-phone SMS platform that identifies prodromal symptoms of relapse, to enable early intervention and prevent unnecessary hospitalizations. Its we...
متن کاملAntipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.
BACKGROUND Relapse prevention with antipsychotic drugs compared with placebo in patients with schizophrenia has not been sufficiently addressed by previous systematic reviews. We aimed to assess the association between such drugs and various outcomes in patients with schizophrenia to resolve controversial issues. METHODS We searched the Cochrane Schizophrenia Group's specialised register for ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of General Psychiatry
سال: 2000
ISSN: 0003-990X
DOI: 10.1001/archpsyc.57.3.277